acarbose (Prandase) decreases the risk of hypertension and heart disease in PRE-diabetes patients

New evidence suggests that acarbose (Prandase) decreases the risk of hypertension and heart disease in PRE-diabetes patients.

Many of these patients develop type 2 diabetes...and can have up to a 10 times higher risk of heart disease-related death.

Pre-diabetes patients who take acarbose over 3 years have a lower risk of developing diabetes...hypertension...and heart disease.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote